Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
This study is currently recruiting participants.
Verified February 2012 by University of Tennessee
Study NCT01088607   Information provided by University of Tennessee

First Received on March 12, 2010.   Last Updated on February 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Sclerosing Cholangitis
Additional conditions recognized in this trial
Cholangitis
Cholangitis, Sclerosing
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Additional drug interventions recognized in this trial
Ursodeoxycholic Acid
More general drug interventions related to this trial
Cholagogues and Choleretics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Tennessee
Mount Sinai School of Medicine
Ann & Robert H Lurie Children's Hospital of Chicago
University of Colorado, Denver
University of California, San Francisco
University of Pittsburgh
Children's Hospital Medical Center, Cincinnati
Phoenix Children's Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services